Navigation Links
ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS
Date:3/5/2010

of drugs for neurodegenerative diseases, and the development, activity, therapeutic potential and safety of ISIS-SOD1Rx in the treatment of ALS.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such products.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2009, which is on file with the SEC.  Copies of this and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its subsidiaries, including Regulus Therapeutics Inc.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Kinex Pharmaceuticals Initiates a Phase 2 Clinical Trial of KX2-391 in Patients with Prostate Cancer
2. QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission
3. Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Prevention of Recurrent Venous Thromboembolism
4. Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui
5. Romark Initiates Clinical Trial of Alinia for Treatment of Influenza
6. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
7. ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases
8. Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression
9. Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
10. ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis
11. Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 The clinical ... can be the difference between a product,s success or ... map and stratify KOL targets – and then to ... type of strong relationships upon which successful KOL engagement ... pharma companies have identified internal inconsistencies in their KOL ...
(Date:8/29/2014)... 2014 Pomerantz LLP has filed a class ... (NASDAQ: EDAP ) and certain of its ... Court, Southern District of New York ... a class consisting of all persons or entities who ... 30, 2014, inclusive (the "Class Period"). This class action seeks ...
(Date:8/29/2014)... PARK, Calif. , Aug. 29, 2014 ... Medical as CEO and member of the Board of ... decades of medical device development and commercialization experience, including ... field. Mr. Engelson previously served as a Partner of ... as President and CEO of two Foundry start-ups. Mr. ...
Breaking Medicine Technology:Implementing a Strategic Thought Leader Management & Engagement System 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... LAKES, N.J. and HOUSTON, April 13, 2011 BD ... and Waste Management Healthcare Solutions, a subsidiary of Waste ... an agreement to recycle medical sharps waste from hospitals ... the BD ecoFinity™ Life Cycle Solution, an innovative service ...
... ATLANTA, April 12, 2011 Digital Assent ... finalist for this year,s "Top Up-and-Coming Entrepreneur" award, which will ... Innovation Summit from TiE Atlanta, an organization whose mission is ... In 2009 Ibbotson founded Digital Assent and launched its ...
Cached Medicine Technology:BD and Waste Management Launch Initiative to Recycle Medical Sharps 2BD and Waste Management Launch Initiative to Recycle Medical Sharps 3BD and Waste Management Launch Initiative to Recycle Medical Sharps 4Digital Assent CEO Selected as Finalist for 2011 Southeast Entrepreneur Awards 2
(Date:8/30/2014)... Barcelona, Spain Saturday 30 August 2014: The ... oral anticoagulants in pulmonary embolism are published today ... at ESC Congress by Professor Stavros V. Konstantinides ... "2014 ESC Guidelines on the diagnosis and management ... in European Heart Journal (1) and on the ...
(Date:8/29/2014)... 30, 2014 Indosoft, Inc. , ... announces the release of its most advanced contact center ... of new features as well as updates to existing ... , Q-Suite functionality on the presentation side has received ... into the script builder. This WYSIWYG editor allows ...
(Date:8/29/2014)... 29, 2014 According to the latest review ... to lose weight quickly, safely and naturally. The new method ... be amazingly fast, too. , Daily Gossip writes in ... not only teach patients how to eliminate the extra pounds, ... results when it comes to body modeling. , The ...
(Date:8/29/2014)... The new review that can be read on ... system that will permanently eliminate the symptoms of this disease. ... achieve a cure in as fast as 30 to 60 ... about one week. , The Tinnitus Miracle review indicates ... mild hearing loss, pain in the ear and dizziness. Read ...
(Date:8/29/2014)... August 29, 2014 Panic attacks are ... the feeling of intense stress and fear, which appears ... the sufferer, causing insecurity and affecting relationships. , A ... there are many symptoms that patients can deal with. ... these symptoms. Overcoming panic attacks is extremely important for ...
Breaking Medicine News(10 mins):Health News:First recommendations on all new oral anticoagulants in pulmonary embolism published 2Health News:Indosoft Releases Q-Suite 5.7.7 2Health News:Flat Belly Forever Review Exposes the Way to Eliminate Body Fat Easily 2Health News:Tinnitus Miracle Review Reveals How to Gain Tinnitus Relief in 7 Days 2Health News:60 Second Panic Solution Review Exposes Simple Panic Attacks Remedy 2
... N.C., March 25 There is no guarantee ... after its initial launch. A,necessary first step for ... that ensures needed resources -- both financial and,staffing ... a study by benchmarking,leader Best Practices, LLC., ...
... Stanford University School of Medicine,s Todd Ferris, Associate ... of Information Privacy and Security; ... Engineer, WHAT: "Improving Network Security and Management", WHEN: ... EDUCAUSE Western Regional Conference 2008 ...
... March 25 Laerdal Medical,Corporation announces a ... MedAssets Supply Chain Systems has awarded Laerdal,a ... Products." The,contract is effective January 1 through ... ), Bruce Cadwell, Laerdal,s National ...
... Cancer with State-of-the-Art Technology, EAST RUTHERFORD, N.J., ... of the nation,s top 10 public relations firms, ... roster. Developed in New,Zealand, MoleSafe is a state-of-the-art ... moles and other suspicious lesions to,help detect early ...
... 25 Almost Family, Inc.,(Nasdaq: AFAM ) today ... home health agency owned by Apex Home Healthcare,Services, L.L.C. ... Company Comments on Combination, "We are very pleased ... of Apex to our Company, and we are excited ...
... pathogens - including ,superbug, MRSA-responsible ... March 25 The U.S. Environmental Protection,Agency (EPA) ... public health claims. These public health claims acknowledge ... harmful, potentially deadly,bacteria. Copper is the first solid ...
Cached Medicine News:Health News:Successful Drug Re-Launch Hinges on Organizational Backing 2Health News:Stanford University School of Medicine to Address 'Improving Network Security and Management' at EDUCAUSE Western Regional Conference 2008 Using Lancope's StealthWatch System for Network Behavior Analysis 2Health News:Laerdal Medical Announces Strategic Relationship 2Health News:MWW Group Retained by MoleSafe 2Health News:Almost Family Announces Acquisition of Apex Home Health 2Health News:Almost Family Announces Acquisition of Apex Home Health 3Health News:Almost Family Announces Acquisition of Apex Home Health 4Health News:U.S. EPA Approves Registration of Antimicrobial Copper Alloys 2
Shandon Laser MicroWriter is a laser labeling system developed specifically for anatomical pathology....
Modular Slide Storage Cabinet has a durable cold rolled steel construction with baked on epoxy finish. Drawers slide smoothly and quietly....
Store microscope slides with ease, speed, efficiency....
... offers special drawers for just about everything imaginable ... microscopy laboratory. Each box is designed for long ... the advantages of wood over metal systems is ... as a subtle kind of desiccator and insulator, ...
Medicine Products: